Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.30%
#2 Victoria VR Victoria VR +9.12%
#3 Movement Movement +8.40%
#4 COTI COTI +7.33%
#5 DMT-NAT DMT-NAT +6.93%
#6 Palladium Network Palladium Network +4.63%
#7 Prom Prom +4.55%
#8 Test Test +4.07%
#9 GRVT Token GRVT Token +3.80%
#10 Cryptopia Cryptopia +3.74%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Life Stem Genetics Inc. Life Stem Genetics Inc.

Life Stem Genetics Inc.

LIFS
Rank in Stocks #42117
Life Stem Genetics Inc., an enterprise currently in its development phase, is... Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.
Share Price
$0.0001
Last synced: 2026-08-12
Market Cap
$4.58K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Life Stem Genetics Inc. (LIFS)

Category

Healthcare
Stock price history for Life Stem Genetics Inc. (LIFS)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $0.08 on 2013-10-01
Stock price history of Life Stem Genetics Inc. from 2013 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 100.00%
2024 -96.55%
2023 544.44%
2022 350.00%
2021 -25.19%
2020 -17.08%
2019 84.98%
2018 -62.11%
2017 6.15%
2016 -75.24%
2015 -50.54%
2014 -91.82%
2013 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.44%
KR